Carvedilol Post-Intervention long-Term Administration in Large-scale Randomized Controlled Trial
Not Applicable
- Conditions
- Acute myocardial infarction
- Registration Number
- JPRN-UMIN000003256
- Lead Sponsor
- Department of Cardiovascular Medicine, Kyoto University Hospital
- Brief Summary
During median follow-up of 3.9 years with 96.4% follow-up, the cumulative 3-year incidences of both the primary endpoint and any coronary revascularization were not significantly different between the carvedilol and no beta-blocker groups :6.8% and 7.9%, P=0.20, and 20.3% and 17.7%, P=0.65, respectively.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 801
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with contraindication for beta-blocker 2)Patients with left ventricular ejection fraction less than 40% 3)Patients with implantable cardioverter defibrillators 4)Patients with end-stage malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method